Medical News

RSS

Bayer Consumer Care introduces One A Day Menopause Formula to help address hot flashes

September is Menopause Awareness Month and women starting the transition into menopause have more information and resources than ever to start taking control of their menopause symptoms. Bayer Consumer Care now introduces One A Day® Menopause Formula, a complete multivitamin with soy isoflavones to help address hot flashes and mild mood changes.

7 Sep 2010

Complete Genomics, SAIC-Frederick collaborate to validate somatic mutations from pediatric cancer cases

Complete Genomics Inc., a life sciences company focused on human genome sequencing, today announced a collaboration to identify and validate somatic mutations from 50 pediatric cancer cases from multiple research centers across the United States.

7 Sep 2010

British, Austrian scientists awarded K. J. Zülch Prize for basic neurological research

British and Austrian scientists receive award for basic neurological research. Alastair Compston and Hans Lassmann are this year's recipients of the K. J. Zülch Prize for basic neurological research. In bestowing this award, the Gertrud Reemtsma Foundation is honouring two scientists who have made crucial contributions to research on multiple sclerosis. Alastair Compston's work has provided important insights into the genetics and treatment of multiple sclerosis.

7 Sep 2010

St. Jude Medical to invest $60M in CardioMEMS

St. Jude Medical, Inc., a global medical device company, and privately-held CardioMEMS today announced that they have reached an agreement under which St. Jude Medical will make a $60 million equity investment in CardioMEMS, a medical device company that has developed a wireless sensing and communication technology to assess cardiac performance.

7 Sep 2010

Carolinas Healthcare System and Medicity partner to build multi-state health information exchange

Carolinas HealthCare System, one of the leading healthcare organizations in the Southeast with 32 affiliated hospitals in North and South Carolina, announced today it has selected Medicity as its partner to build a multi-state health information exchange.

7 Sep 2010

Estee Lauder subsidiary and OXIS resolve mitochondria patent dispute

OXIS INTERNATIONAL, INC. and THE ESTEE LAUDER COMPANIES INC. announce today that they have resolved a dispute between an Estee Lauder subsidiary, Applied Genetics Incorporated Dermatics, and Oxis over technology related to U.S. Patent No. 6,103,746 and U.S. Patent No. 6,479,533, entitled "Methods and Compositions for the Protection of Mitochondria."

7 Sep 2010

Rexahn submits Phase IIb protocol to FDA for study of Serdaxin for major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).

7 Sep 2010

FINRA approves Curaxis' change of trading symbol to 'CURX'

Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp., announced today that the Financial Industry Regulatory Authority has approved the change of the company's trading symbol on the OTCBB market from ASCH to CURX effective immediately.

7 Sep 2010

K2M granted FDA clearance for CHESAPEAKE Anterior-Lumbar Stabilization System

K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its new CHESAPEAKE™ Anterior-Lumbar Stabilization System, a unique interbody device designed for stabilization of the spine through an anterior approach. The system provides screw fixation through K2M's revolutionary tifix® Locking Technology, whereby each screw head forms an autogenic lock to the implant upon insertion.

7 Sep 2010

Somaxon's Silenor now commercially available in U.S.

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that Silenor® (doxepin) now is commercially available by prescription in the United States. Somaxon has implemented a wholesale and retail stocking program to disseminate Silenor 3 mg and 6 mg dosepacks to pharmacies across the United States. Silenor is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.

7 Sep 2010

CytRx commences PROACT Phase 2 clinical trial of bafetinib for advanced prostate cancer

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced initiation of the PROstate Advanced Cancer Treatment (PROACT) Phase 2 proof-of-concept clinical trial to evaluate the efficacy and safety of bafetinib in patients with advanced prostate cancer.

7 Sep 2010

Promedior initiates PRM-151 Phase 2a clinical study in prevention of scarring post glaucoma filtration surgery

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today that it has initiated a Phase 2a clinical study of PRM-151 to evaluate the efficacy, safety, and tolerability of PRM-151 in preventing post-surgical scarring in glaucoma patients following glaucoma filtration surgery. There currently are no approved drugs for preventing post-surgical scarring in glaucoma, and there are no approved anti-fibrotic drug therapies in the U.S. or Europe for any fibrotic disease.

7 Sep 2010

KHN column: Social Security's Disabled Adult Child program: A key program often below the radar

In this Kaiser Health News column, Harold Pollack writes: "Intellectual disability is often accompanied by costly illnesses and social service needs.

7 Sep 2010

TSO3 engaged in regulatory discussions for refiling of new generation sterilizer's 510(k) clearance

TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company is having productive discussions with US regulators, including a very recent face-to-face meeting. The Company is actively engaged in the changing US regulatory process intended to lead to the refilling for 510(k) clearance on its new generation sterilizer.

7 Sep 2010

Health 2.0 Developer Challenge: Teams are putting final touches on their applications

With only a few weeks left until the deadlines of the Health 2.0 Developer Challenge more than 40 teams are putting the final touches on their applications for the 10 prizes. Winners will be announced by Todd Park, CTO of U.S. Dept. of Health and Human Services (HHS), and Aneesh Chopra, Federal CTO, at the Health 2.0 Conference on October 7-8, in San Francisco.

7 Sep 2010

Lionsgate, Jane Fonda enter deal to improve high-profile fitness

Reflecting an overall strategy of allying itself with world-class, brand name partners in all of its businesses, LIONSGATE, the leading next generation studio, has entered into a home entertainment distribution deal with Jane Fonda, the two time Academy Award winning actress and fitness pioneer who first coined the term "workout" in the 1980s.

7 Sep 2010

Positive immune responses elicited from Scancell's DNA vaccine in combination with ImmuneRegen's Homspera

Scancell Holdings Plc, the developer of therapeutic cancer vaccines, announces that a treatment utilising a DNA vaccine based on its ImmunoBody® technology, in combination with ImmuneRegen BioSciences, Inc.®'s lead compound, Homspera®, has significantly improved the immune response of the vaccine in an animal model. Follow-up studies are currently being performed to optimize the effects of Homspera in enhancing the next generation of Scancell's cancer vaccines.

7 Sep 2010

Nassau University Medical Center to include Streamline Health Solutions' HIM Suite of workflows

Streamline Health Solutions, Inc. a leading provider of document workflow solutions for hospitals, today announced that Nassau University Medical Center in East Meadow, New York, will expand its software licensing arrangement to include Streamline Health's Enterprise Health Information Management Suite of workflows.

7 Sep 2010

Tiger Balm sponsors Susan G. Komen NYC Race for the Cure to help raise awareness on breast cancer

Tiger Balm announced today its sponsorship of the 20th annual Susan G. Komen NYC Race for the Cure, taking place Sunday, September 12, 2010 in New York's Central Park.

7 Sep 2010

AuthenTec, UPEK combine to expand fingerprint sensors and identity management software

AuthenTec, a leading provider of security, identity management and touch control solutions, and privately-held UPEK, a leading supplier of fingerprint solutions for consumer, business and government applications, announced that the companies have combined, creating the world's largest provider of fingerprint sensors and identity management software, as well as biometric and embedded security solutions.

7 Sep 2010

Medical News

Bayer Consumer Care introduces One A Day Menopause Formula to help address hot flashes

Complete Genomics, SAIC-Frederick collaborate to validate somatic mutations from pediatric cancer cases

British, Austrian scientists awarded K. J. Zülch Prize for basic neurological research

St. Jude Medical to invest $60M in CardioMEMS

Carolinas Healthcare System and Medicity partner to build multi-state health information exchange

Estee Lauder subsidiary and OXIS resolve mitochondria patent dispute

Rexahn submits Phase IIb protocol to FDA for study of Serdaxin for major depressive disorder

FINRA approves Curaxis' change of trading symbol to 'CURX'

K2M granted FDA clearance for CHESAPEAKE Anterior-Lumbar Stabilization System

Somaxon's Silenor now commercially available in U.S.

CytRx commences PROACT Phase 2 clinical trial of bafetinib for advanced prostate cancer

Promedior initiates PRM-151 Phase 2a clinical study in prevention of scarring post glaucoma filtration surgery

KHN column: Social Security's Disabled Adult Child program: A key program often below the radar

TSO3 engaged in regulatory discussions for refiling of new generation sterilizer's 510(k) clearance

Health 2.0 Developer Challenge: Teams are putting final touches on their applications

Lionsgate, Jane Fonda enter deal to improve high-profile fitness

Positive immune responses elicited from Scancell's DNA vaccine in combination with ImmuneRegen's Homspera

Nassau University Medical Center to include Streamline Health Solutions' HIM Suite of workflows

Tiger Balm sponsors Susan G. Komen NYC Race for the Cure to help raise awareness on breast cancer

AuthenTec, UPEK combine to expand fingerprint sensors and identity management software

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News